Stock Rating Upgrade
In the last week the Value Trend Rating for Neogenomics Inc (NASDAQ: NEO) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Neogenomics Inc (NASDAQ: NEO) stock closed at $11.10 on 2/21/25 after a large decline of -6.4%. Moreover, unusually high trading volume at 178% of normal accompanied the decline. The stock has declined -19.4% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Neogenomics has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Neogenomics has a slightly negative Appreciation Score of 36 and a neutral Power Rating of 53, with the Low Neutral Value Trend Rating the result.
Be the first to comment